ANNE C. WHITAKER

Corporate Board Profile

Tech Score: 0/100

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2021-04-28	Anne C. Whitaker joined the Caladrius Board in November 2020. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Ms. Whitaker. ... The Science and Technology Committee consists of Drs. Davidson (Chairman), Brown, Traber, Mazzo, Mr. Klosk, Ms. Schwalm and Ms. Whitaker. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2020. ... Anne Whitaker $8,371 Fees Earned in Cash, $120,000 Stock Awards, $0 Option Awards, $128,371 Total Compensation.

Filing Date

Source Excerpt

2021-04-28

Anne C. Whitaker joined the Caladrius Board in November 2020. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Ms. Whitaker. ... The Science and Technology Committee consists of Drs. Davidson (Chairman), Brown, Traber, Mazzo, Mr. Klosk, Ms. Schwalm and Ms. Whitaker. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2020. ... Anne Whitaker $8,371 Fees Earned in Cash, $120,000 Stock Awards, $0 Option Awards, $128,371 Total Compensation.

WOLFSPEED, INC.

Filing Date	Source Excerpt
2014-09-09	Ms. Whitaker brings to the Board her experience as a senior executive and commercial leader in sales and marketing, as well as human resource experience beneficial to the Company.
2015-09-08	Ms. Whitaker brings to the Board her experience as a senior executive and commercial leader in sales and marketing, as well as human resource experience beneficial to the Company.
2016-09-06	Ms. Whitaker joined the Board of Directors in December 2013. Since May 2015, she has served as Executive Vice President and Company Group Chairman of Valeant Pharmaceuticals International, Inc., a publicly traded multinational specialty pharmaceutical company headquartered in Québec, Canada.
2017-09-08	Ms. Whitaker brings to the Board her experience as a senior executive and commercial leader in sales and marketing, as well as human resource experience beneficial to the Company as we seek to grow the Company and expand our leadership capabilities.
2018-09-07	Ms. Whitaker brings to the Board her experience as a publicly traded CEO along with more than a decade of senior executive commercial and human resource experience at some of the most respected publicly traded global pharmaceutical companies in the world.
2019-09-10	Ms. Whitaker brings to the Board her experience as a CEO of a publicly traded company along with senior executive commercial and human resource experience at pharmaceutical companies.
2020-09-09	She has served as CEO and senior executive in pharmaceutical companies and has commercial and human resource experience, with no mention of software or technical background.

Data sourced from SEC filings. Last updated: 2025-08-30